I think the downturn would continue if no news coming out.
lots of traders entered with the anticipation of antigen contract, if nothing eventuate, they'll likely to exit
From what I've read, antibody tests do not have much market. And antigen tests for AT1 are only for Australia with lots of competitors. What I'm counting on is the lumos FDA, that could be the game changer
